Clinical Trial Highlights

• Comparison of Treatments for HR+ Early Breast Cancer
• Docetaxel at Beginning of Androgen Deprivation Therapy Boosts Overall Survival by over 1 Year
• Lenvatinib Improves Progression-Free Survival in Refractory Thyroid Cancer
• Ramucirumab Improves Survival in Stage IV NSCLC
• Lapatinib Plus Trastuzumab Was Not Superior to Trastuzumab Alone or Trastuzumab Followed by Lapatinib for Improved DFS in Women with HER2+ Breast Cancer
• Obesity Linked to ER+ Breast Cancer Mortality in Premenopausal Women
• Similar Benefit of Immediate or Deferred ADT in PSA-Only Relapsed Prostate Cancer
• CALGB/SWOG 80405 Results Provide Treatment Options for mCRC
• Goserelin Improves Ovarian Function in Premenopausal Women with Estrogen Receptor-Negative/Progesterone Receptor-Negative Breast Cancer
• CRT with Oxaliplatin Improves DFS in Locally Advanced Rectal Cancer
• Safety and Efficacy of Enzalutamide in Men with Metastatic Prostate Cancer: The PREVAIL Trial